Haoxuan Zhong

180 Fenglin Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Exosome-mediated transfer of NOD2 from platelets to monocytes: a novel therapeutic target for atherosclerosis.

Exosome-mediated transfer of NOD2 from platelets to monocytes: a novel therapeutic target for atherosclerosis.

Journal: Biochemical pharmacology

Published: March 31, 2026

Calcitriol Suppresses Platelet Activation and Thrombosis, Mitigating Cardiovascular Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Calcitriol Suppresses Platelet Activation and Thrombosis, Mitigating Cardiovascular Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: JACC. Basic to translational science

Published: January 08, 2026

IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signaling.

IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signaling.

Journal: Biochemical pharmacology

Published: October 04, 2025

Endoplasmic Reticulum Stress-Induced triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Downregulation Exacerbates Platelet Activation and Myocardial Infarction in Patients With Coronary Artery Disease.

Endoplasmic Reticulum Stress-Induced triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Downregulation Exacerbates Platelet Activation and Myocardial Infarction in Patients With Coronary Artery Disease.

Journal: Journal of the American Heart Association

Published: June 24, 2025

Thyroid-stimulating hormone enhances platelet activation and arterial thrombosis.

Thyroid-stimulating hormone enhances platelet activation and arterial thrombosis.

Journal: Cardiovascular research

Published: May 23, 2025

ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly.

ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly.

Journal: Cardiovascular research

Published: April 17, 2025

Illicit drug N-ethylpentylone potentiates platelet activation through 5-hydroxytryptamine2A receptor-mediated mitogen-activated protein kinase signaling.

Illicit drug N-ethylpentylone potentiates platelet activation through 5-hydroxytryptamine2A receptor-mediated mitogen-activated protein kinase signaling.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 26, 2025

Enhanced STIM1 expression drives platelet hyperactivity in diabetes.

Enhanced STIM1 expression drives platelet hyperactivity in diabetes.

Journal: Biochemical and biophysical research communications

Published: February 12, 2025

The soluble guanylate cyclase (sGC) stimulator vericiguat inhibits platelet activation and thrombosis.

The soluble guanylate cyclase (sGC) stimulator vericiguat inhibits platelet activation and thrombosis.

Journal: European journal of pharmacology

Published: December 10, 2024

20-HETE induced platelet activation via a GPR75-independent pathway.

20-HETE induced platelet activation via a GPR75-independent pathway.

Journal: Thrombosis research

Published: November 22, 2024

USP25-mediated talin-1 stabilization in platelets: a novel mechanism of hyperreactivity and thrombosis risk during aging.

USP25-mediated talin-1 stabilization in platelets: a novel mechanism of hyperreactivity and thrombosis risk during aging.

Journal: Blood

Published: September 27, 2024

Intermittent fasting inhibits platelet activation and thrombosis through the intestinal metabolite indole-3-propionate.

Intermittent fasting inhibits platelet activation and thrombosis through the intestinal metabolite indole-3-propionate.

Journal: Life metabolism

Published: September 25, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026